Biotech

All Articles

ReNeuron leaving behind goal exchange after overlooking fundraising target

.ReNeuron has signed up with the lengthy list of biotechs to leave behind Greater london's purpose s...

MBX declare IPO to take opposition to Ascendis right into phase 3

.MBX Biosciences has actually included in the latest flurry of IPO filings. The biotech, which filed...

FDA grows probing in to Lykos' MDMA trials: WSJ

.For Lykos Therapies as well as the provider's would-be MDMA-assisted therapy for post-traumatic str...

Gene editor Volume giving up 131 workers

.Just times after genetics editor Volume Biosciences declared confidential operational cuts, a more ...

Repare lays off 25% of staff as biotech standstills preclinical R&ampD

.Repare Rehab is laying off a fourth of its workforce as the oncology biotech downsize its own precl...

J &amp J files for FDA authorization of $6.5 B autoimmune medication

.Johnson &amp Johnson has gotten one more action toward realizing a return on its own $6.5 billion n...

Gain's phase 1 win leads means to confirm Parkinson's drug's worth

.Gain Therapeutics has actually set its direct showing the performance of its own Parkinson's ailmen...

Actinogen documents brand-new period 2 information to save clinical depression medication

.Actinogen Medical's hopes-- and supply price-- have recoiled somewhat from previously this month, w...

Pfizer and Main add Quotient to multibillion-dollar equation

.Main Pioneering and also Pfizer have actually incorporated Quotient in to their 10-program alliance...

Bayer markers $547M contract to drive perimeters of noncoding RNA

.Bayer execs were actually eager to anxiety to Intense this summer that the German pharma titan's cr...